Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. Januar 2007 08:48 ET | Quelle: MedaSorb Technologies

MedaSorb Announces IDE Filing With the FDA

MONMOUTH JUNCTION, N.J., Jan. 4, 2007 (PRIME NEWSWIRE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) today announced that is has submitted an Investigational Device Exemption (IDE) Supplement to...
19. Dezember 2006 08:54 ET | Quelle: MedaSorb Technologies

MedaSorb Names Former Bristol Meyers Vice Chairman, William R. Miller, as Chairman of the Board

MONMOUTH JUNCTION, N.J., Dec. 19, 2006 (PRIME NEWSWIRE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) announced today the appointment of William R. Miller as Chairman of the Board of Directors,...
13. November 2006 08:48 ET | Quelle: MedaSorb Technologies

MedaSorb Technologies Corporation Files New Patent Application

MONMOUTH JUNCTION, N.J., Nov. 13, 2006 (PRIMEZONE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) announced today that it has filed a new patent application covering its Ultra Select(tm) polymer...
27. Oktober 2006 08:30 ET | Quelle: MedaSorb Technologies

MedaSorb Technologies Adds Strategic Technology Patent

MONMOUTH JUNCTION, N.J., Oct. 27, 2006 (PRIMEZONE) -- MedaSorb Technologies (OTCBB:MSBT) announced today that it has acquired ownership of Patent No. 6,884,829 from Robert Albright, Ph.D., a...
19. September 2006 13:22 ET | Quelle: MedaSorb Technologies

MedaSorb Announces That They Intend to File Investigational Device Exemption With the FDA

MONMOUTH JUNCTION, N.J., Sept. 19, 2006 (PRIMEZONE) -- MedaSorb Technologies, Inc. (OTCBB:MSBT) announced today that they intend to file an Investigational Device Exemption (IDE) with the FDA by the...